Tiantian Liu

14PUBLICATIONS
85CO-AUTHORS
Medical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 15, 2025
ID2 secures cDC1 specification by antagonizing E proteins at a pleiotropic Zeb2 enhancer.

Feiya Ou, Tian-Tian Liu, Siling Du

|Aug 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.

Graham D Hogg, Alyssa G Weinstein, Natalie L Kingston

|May 30, 2025
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.

Miguel Galán, Laura Fernández-Méndez, Vanessa Núñez

|Feb 07, 2025
Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2.

Suin Jo, Ray A Ohara, Derek J Theisen

|Oct 07, 2024
Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregation.

Feiya Ou, Tian-Tian Liu, Pritesh Desai

Pageof 3